ClinicalTrials.gg
Sign In

Cicatrix clinical trials

The registry lists 611 studies for Cicatrix across more than 10 countries. 114 are recruiting or about to start. 433 of them are mainly about Cicatrix (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Keloid: 898 studies, 169 open.

ClinicalTrials.gov finds 1,395 studies for Cicatrix. How that becomes 611 here

This page counts the studies the registry files under Cicatrix, and those it files under no condition that list Cicatrixthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,395Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −285Filed under a narrower condition, counted on its own pageTissue Adhesions 118 · Keloid 100 · Cicatrix, Hypertrophic 67
  3. −112List Cicatrix as a condition, but the registry did not file them under itMost often written as “Acne Scars - Mixed Atrophic and Hypertrophic” (17), “Burn Scar” (16), and “Acne Scars” (9). The registry filed them under other conditions only, most often Burns (19) and Hypertrophy (18).
  4. −387Match it another way231 name it in the title, 49 in a keyword, and 107 by a synonym or other text the search reads.
  5. 611The count on this page204 of them list Cicatrix in their own words; the registry filed them under no condition.

Get an email when these change. Save the Cicatrix studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
318
Status unknown
100
Recruiting
69
Not yet recruiting
40
Withdrawn
31
Terminated
27

Phase

Phase 2
99
Phase 1
50
Phase 3
29
Phase 4
25
Early Phase 1
9

Where

United States
198
Egypt
54
China
40
United Kingdom
29
Canada
28
Italy
19

Who runs them

Renovo (23) · University of California, Davis (15) · Assiut University (10) · Sohag University (9) · Cynosure, Inc. (9) · Massachusetts General Hospital (9) · Northwestern University (8) · Cairo University (7)

What is being tested here

Drugs under test in Cicatrix studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Verteporfin202
Botulinum toxin type A1311
Botulinum Toxins134
Timolol101
RNA, Small Interfering101
Anti-IL-11 Monoclonal Antibody 9MW3811101
Bimatoprost101
Oxytocin101
TGFB3 protein, human0116
EXC 001005

Coming up

6phase 3 studies under way
35studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 69 Cicatrix studies recruiting now, 34 (49%) set no upper age limit and 31 (45%) stop at 75 or younger. 11 (16%) take children under 18. 19 (28%) are for women only and 0 (0%) for men only; 16 (23%) take healthy volunteers.

Recruiting studies that take each age, of 69
AgeWomenMen
106 (9%)5 (7%)
1857 (83%)42 (61%)
3066 (96%)48 (70%)
4063 (91%)48 (70%)
5055 (80%)46 (67%)
6545 (65%)37 (54%)
7538 (55%)30 (43%)
8536 (52%)28 (41%)

Across all 611 studies, recruiting or not: 53% stop at 75 or younger and 45% at 65; 16% take children; 22% are for women only and 1% for men only; 39% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cicatrix studies take

Of 24 phase 2 interventional studies under Cicatrix, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 16 mo6–17 · 16 studies——
Phase 221 mo7–61 · 24 studies——
Interventional, no phase18 mo8–36 · 206 studies9 mo8–20 · 33 studies20 mo9–36 · 173 studies
Observational40 mo7–… · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 611. Browse all 611 → or search them.

Cicatrix clinical trials — 611 studies | ClinicalTrials.gg